CIA
DNA icon

Cape Investment Advisory’s Ginkgo Bioworks DNA Stock Holding History

Cape Investment Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12
Closed -$175 – 1318
2025
Q3 		$175 Hold
12
– – ﹤0.01% 823
2025
Q2 		$135 Hold
12
– – ﹤0.01% 1134
2025
Q1 		$68 Hold
12
– – ﹤0.01% 1112
2024
Q4 		$118 Hold
12
– – ﹤0.01% 1082
2024
Q3 		$98 Sell
12
-1
-8% -$10 ﹤0.01% 941
2024
Q2 		$167 Sell
13
-250
-95% -$7.46K ﹤0.01% 902
2024
Q1 		$12.2K Buy
263
+250
+1,923% +$12.9K 0.01% 514
2023
Q4 		$845 Hold
13
– – ﹤0.01% 1028
2023
Q3 		$905 Hold
13
– – ﹤0.01% 842
2023
Q2 		$930 Buy
+13
New +$770 ﹤0.01% 831

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return